No Data
No Data
Analysts Have Conflicting Sentiments on These Healthcare Companies: Legend Biotech (LEGN), Molina Healthcare (MOH) and Edwards Lifesciences (EW)
Barclays Maintains Legend Biotech(LEGN.US) With Buy Rating, Maintains Target Price $94
Wall Street Analysts Believe Legend Biotech (LEGN) Could Rally 90.83%: Here's Is How to Trade
Press Release: Legend Biotech to Host Investor Conference Call on Third Quarter 2024 Results
HK Stock Market News | Genscript Bio (01548) fell nearly 5% in the afternoon, Genscript Financials no longer consolidated with legend biotech. The company clarifies the rumors of selling the cell business.
genscript bio (01548) fell nearly 5% in the afternoon, as of the time of publication, down 4.58%, at 12.08 Hong Kong dollars, with a turnover of 87.4963 million Hong Kong dollars.
Legend Biotech Faces Financial Restructuring Amid Voting Changes